An Umbrella Study to Explore Precision Treatment of Colorectal Cancer Based on Molecular Typing

ABSTRACT: Interventions: Cohort 1:PD-L1 monoclonal antibody+HER2 monoclonal antibody+HER2 TKI;Cohort 2:HER2 TKI+Investigator assigned chemotherapy;Cohort 3:Cetuximab + MEK Inhibitor;Cohort 4:PARP Inhibitor + Irinotecan Primary outcome(s): Objective Response Rate Study Design: Factorial

DISEASE(S): Colorectal Cancer

PROVIDER: 2698986 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR